Therefore, the siRNA‐CaP@PD1‐NVs improved the tumor immune‐suppressive microenvironment, enhanced the infiltration and activity of CD8+ T cells, and promoted DC cell maturation and formed long‐term immune memory, leading to significantly inhibit tumor growth or even eliminate exist tumors, and effectively prevent tumor recurrence and metastasis. Here, CD8A is linked to neoplasm.